EPO and chronic mountain sickness: Von Hippel-Lindau (VHL) methylation has been shown to upregulate the hypoxia-inducible factor-1α (HIF-1α)/erythropoietin (EPO) pathway in rat bone marrow, leading to excessive red blood cell proliferation in chronic mountain sickness [8].